PTCT

PTC Therapeutics, Inc. Press Releases

$27.86
*  
0.49
1.73%
Get PTCT Alerts
*Delayed - data as of Jul. 24, 2014 13:45 ET  -  Find a broker to begin trading PTCT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PTCT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

PTC Therapeutics Announces Expanded Access Program For Translarna™ (ataluren)
7/9/2014 2:00:00 PM - PR Newswire

ContraVir Appoints Industry Veteran William Hornung as Its Chief Financial Officer
7/8/2014 6:00:00 AM - Business Wire

PTC Therapeutics Initiates Confirmatory Phase 3 Clinical Trial of Translarna™ (ataluren) in Patients with Nonsense Mutation Cystic Fibrosis (nmCF)
6/30/2014 8:00:00 AM - PR Newswire

PTC Therapeutics Recipient of Parent Project Muscular Dystrophy's "Path to Progress" Award
6/30/2014 8:00:00 AM - PR Newswire

PTC Therapeutics to Present at the 9th Annual JMP Securities Healthcare Conference
6/17/2014 8:00:00 AM - PR Newswire

Shane Kovacs Receives the 2014 New Jersey Technology Council CFO - Deal of the Year Award
6/13/2014 8:00:00 AM - PR Newswire

PTC Therapeutics Appoints Ronald C. Renaud, Jr. to Board of Directors
6/11/2014 8:00:00 AM - PR Newswire

PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
6/10/2014 4:30:00 PM - PR Newswire

PTC Therapeutics Receives Positive Opinion from CHMP for Translarna™ (ataluren)
5/23/2014 7:53:00 AM - PR Newswire

PTC Therapeutics Provides EMA Update
5/23/2014 7:30:00 AM - PR Newswire

PTC Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference
5/21/2014 4:30:00 PM - PR Newswire

Ataluren Phase 3 Trial Results in Nonsense Mutation Cystic Fibrosis Published in The Lancet Respiratory Medicine
5/16/2014 8:00:00 AM - PR Newswire

PTC Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
5/6/2014 4:01:00 PM - PR Newswire